Compounds > venticute
Page last updated: 2024-11-13

venticute

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Venticute: a recombinant surfactant protein C-based surfactant preparation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71454399
CHEMBL ID2218909
MeSH IDM0512398

Synonyms (12)

Synonym
b9420-001
6mct347y2b ,
(5-l-phenylalanine,6-l-phenylalanine,33-l-isoleucine)human pulmonary surfactant-associated protein c-(2-35)-peptide
unii-6mct347y2b
2-35-lipoprotein sp-c (human pulmonary surfactant-associated reduced), 5-l-phenylalanine-6-l-phenylalanine-33-l-isoleucine-
glycly-l-isoleucyl-l-prolyl-l-phenylalanyl-l-phenylalanyl-l-prolyl-l-valyl-l-histidyl-l-leucyl-l-lysyl-l-arginyl-l-leucyl-l-leucyl-l-isoleucyl-l-valyl-l-valyl-l-valyl-l-valyl-l-valyl-l-valyl-l-leucyl-l-isoleucyl-l-valyl-l-valyl-l-valyl-l-isoleucyl-l-valyl
lusupultide [usan:inn]
lusupultide
b-9420-001
CHEMBL2218909
rsp-c surfactant
venticute
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (85.71)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.70 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews2 (28.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
herbimycin
herbimycin: herbicidal antibiotic produced by Streptomyces sp.; see also herbimycin B; structure for herbimycin A in second source. herbimycin : A 19-membered macrocyle incorporating a benzoquinone ring and a lactam functionality. It is an ansamycin antibiotic that induces apoptosis and displays antitumour effects.		2.05101,4-benzoquinones;
lactam;
macrocycle		antimicrobial agent;
apoptosis inducer;
herbicide;
Hsp90 inhibitor;
tyrosine kinase inhibitor
interleukin-8
Interleukin-8: A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells.		2.0510
ConditionIndicatedRelationship StrengthStudiesTrials
Acute Respiratory Distress Syndrome
[description not available]		05.7341
Respiratory Distress Syndrome
A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.		05.7341
Asthma, Bronchial
[description not available]		02.0510
Asthma
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).		02.0510